{Reference Type}: Journal Article
{Title}: Management of NSAID-associated peptic ulcer disease.
{Author}: Melcarne L;García-Iglesias P;Calvet X;
{Journal}: Expert Rev Gastroenterol Hepatol
{Volume}: 10
{Issue}: 6
{Year}: Jun 2016
{Factor}: 4.095
{DOI}: 10.1586/17474124.2016.1142872
{Abstract}: Non-steroidal anti-inflammatory drug (NSAID) use increases the risk of gastrointestinal complications such as ulcers or bleeding. The presence of factors like advanced age, history of peptic ulcer, Helicobacter pylori infection and the use of anticoagulants or antiplatelet agents increase this risk further. COX-2 inhibitors and antisecretory drugs, particularly proton pump inhibitors, help to minimize the risk of gastrointestinal complications in high-risk patients. This review presents a practical approach to the prevention and treatment of NSAID-associated peptic ulcer disease and examines the new advances in the rational use of NSAIDs.